What changed at WXT in November, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Testing Dispatch
Medutest result on a Tianjin tirzepatide lot lands 4.3 points below the supplier’s figure
The supplier has not disputed the finding. It has not explained the gap either.
A peptide content determination commissioned by the Journal on a 20 mg tirzepatide vial from BCH has returned 90% of the labelled mass. Chromatographic purity on the same vial was above 96.9%. The two numbers measure different things and only one of them was on the certificate.
Content by elemental nitrogen determination returned 90% of the labelled nominal mass, which on a 20 mg vial corresponds to roughly 13.74 mg of peptide rather than the labelled figure. The remainder is accounted for by counter-ion, residual water and residual solvent, none of which is visible chromatographically.
Content by elemental nitrogen determination returned 90% of the labelled nominal mass, which on a 20 mg vial corresponds to roughly 13.74 mg of peptide rather than the labelled figure. The remainder is accounted for by counter-ion, residual water and residual solvent, none of which is visible chromatographically.
Discrepancies of one to two percentage points between a supplier’s figure and an independent determination are common and usually explicable: a faster gradient resolves fewer impurities, a higher integration threshold discards more small peaks, and a wider solvent-front exclusion window removes early-eluting fragments from the calculation altogether. None of that is misconduct. All of it is invisible unless the method is disclosed.
"The useful thing in that report is not the percentage, it is the system suitability data," said Rowena Ashcombe, community pharmacist and diabetes educator. "It is the only part that tells you whether the percentage means anything."
BCH’s dossier has been updated with this determination and with the date of the request for comment. The dossier’s "what we could not verify" box records the questions still outstanding.
Related coverage
What a purity certificate is silent about
A purity figure is silent on peptide content, on water, on counter-ion, on sterility, on endotoxin and on stability. Each of those silences has a price attached.
What twenty companies say about storage, and what they have measured
Storage instructions in this market are close to uniform and almost never accompanied by the study that would justify them. Uniformity is a sign of convention, not of…
Holograms, QR codes and other things that are not verification
Reported from the analysis, not from a warning notice.
Soft ionisation: the twenty-year-old trick that made peptide identity routine
A brief and unromantic tour of the interface between a liquid sample and a vacuum.
The retest date and the expiry date are not the same document
A retest date says that material should be re-examined before use. An expiry date says it should not be used. The trade uses the second word for the first concept.